IMMUNOGENICITY RISK ASSESSMENT USING PRE-CLINICAL TOOLS FOR BIOTHERAPEUTICS

被引：0
|
作者：
Shi, Pu [1 ]
Gemski, Christopher [1 ]
Zhou, Li [1 ]
Wu, Jing-Tao [1 ]
Xia, Cindy [1 ]
机构：
[1] Takeda Pharmaceut Int Co, Cambridge, MA USA
来源：
DRUG METABOLISM AND PHARMACOKINETICS | 2018年 / 33卷 / 01期
关键词：
D O I：
10.1016/j.dmpk.2017.11.220
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P136
引用
收藏
页码：S65 / S66
页数：6
相关论文
共 50 条
  • [1] Pre-Clinical Considerations in the Assessment of Immunogenicity for Protein Therapeutics
    Baker, Matthew P.
    Carr, Francis J.
    [J]. CURRENT DRUG SAFETY, 2010, 5 (04) : 308 - 313
  • [2] Assay format diversity in pre-clinical immunogenicity risk assessment: Toward a possible harmonization of antigenicity assays
    Ducret, Axel
    Ackaert, Chloe
    Bessa, Juliana
    Bunce, Campbell
    Hickling, Timothy
    Jawa, Vibha
    Kroenke, Mark A.
    Lamberth, Kasper
    Manin, Anais
    Penny, Hweixian L.
    Smith, Noel
    Terszowski, Grzegorz
    Tourdot, Sophie
    Spindeldreher, Sebastian
    [J]. MABS, 2022, 14 (01)
  • [3] Risk-based approach of bioanalytical methods for clinical immunogenicity assessment of multidomain biotherapeutics
    Mao, Yan
    Coble, Kelly
    [J]. BIOANALYSIS, 2024, 16 (05)
  • [4] Survey Outcome on Immunogenicity Risk Assessment Tools for Biotherapeutics: an Insight into Consensus on Methods, Application, and Utility in Drug Development
    Jochem Gokemeijer
    Yi Wen
    Vibha Jawa
    Shibani Mitra-Kaushik
    Shan Chung
    Alan Goggins
    Seema Kumar
    Kasper Lamberth
    Karen Liao
    Jennie Lill
    Qui Phung
    Robin Walsh
    Brian J. Roberts
    Michael Swanson
    Inderpal Singh
    Sophie Tourdot
    Mark A. Kroenke
    Bonita Rup
    Theresa J. Goletz
    Swati Gupta
    Laurent Malherbe
    Sofie Pattijn
    [J]. The AAPS Journal, 25
  • [5] Survey Outcome on Immunogenicity Risk Assessment Tools for Biotherapeutics: an Insight into Consensus on Methods, Application, and Utility in Drug Development
    Gokemeijer, Jochem
    Wen, Yi
    Jawa, Vibha
    Mitra-Kaushik, Shibani
    Chung, Shan
    Goggins, Alan
    Kumar, Seema
    Lamberth, Kasper
    Liao, Karen
    Lill, Jennie
    Phung, Qui
    Walsh, Robin
    Roberts, Brian J. J.
    Swanson, Michael
    Singh, Inderpal
    Tourdot, Sophie
    Kroenke, Mark A. A.
    Rup, Bonita
    Goletz, Theresa J. J.
    Gupta, Swati
    Malherbe, Laurent
    Pattijn, Sofie
    [J]. AAPS JOURNAL, 2023, 25 (04):
  • [6] Pre-clinical immunogenicity 'check up' of biotherapeutic drugs
    Prior, S.
    Smith, N.
    Gansemans, Y.
    Stallwood, Y.
    Pattijn, S.
    Stas, P.
    [J]. IMMUNOLOGY, 2011, 135 : 82 - 82
  • [7] Preclinical immunogenicity risk assessment of biotherapeutics using CD4 T cell assays
    Walsh, Robin E.
    Nix, Angela
    Ackaert, Chloe
    Mazy, Aurelie
    Schockaert, Jana
    Pattyn, Sofie
    Malherbe, Laurent
    [J]. FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [8] Immunogenicity risk assessment and mitigation tools
    Osmani, Amin
    Pattijn, Sofie
    Schockaert, Jana
    Mazy, Aurelie
    Ackaert, Chloe
    [J]. CANCER RESEARCH, 2020, 80 (16)
  • [9] Biosimilars and biobetters as tools for understanding and mitigating the immunogenicity of biotherapeutics
    Barbosa, Maria D. F. S.
    Kumar, Sandeep
    Loughrey, Helen
    Singh, Satish K.
    [J]. DRUG DISCOVERY TODAY, 2012, 17 (23-24) : 1282 - 1288
  • [10] Tools for Functional Assessment of Biotherapeutics
    Rathore, Anurag S.
    Dash, Rozaleen
    Jain, Ritu
    Auclair, Jared
    [J]. LC GC NORTH AMERICA, 2021, 39 (06) : 272 - 277
12345